FDA Approved: LIVALO — Supplemental Application (Kowa Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for LIVALO (pitavastatin calcium) from Kowa Pharmaceuticals America, updating the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Dyslipidemia
• Hyperlipidemia

Drugs mentioned

• LIVALO (pitavastatin calcium)

Snippet

SUPPL AP for LIVALO (PITAVASTATIN CALCIUM)